These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17545118)

  • 1. [Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda].
    Székely E; Tasnádi G; Szentmihályi K; Almási A; Bor M; Fehér J; Blázovics A
    Orv Hetil; 2007 Jun; 148(23):1095-100. PubMed ID: 17545118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major and trace elements in whole blood of phlebotomized patients with porphyria cutanea tarda.
    Dinya M; Székely E; Szentmihályi K; Tasnádi G; Blázovics A
    J Trace Elem Med Biol; 2005; 19(2-3):217-20. PubMed ID: 16325539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer.
    Székely E; Bor M; Tasnádi G; Várnai K; Almási A; Blázovics A
    Clin Hemorheol Microcirc; 2006; 35(3):387-96. PubMed ID: 16899961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda--when skin meets liver.
    Frank J; Poblete-Gutiérrez P
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):735-45. PubMed ID: 20955974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda.
    Elder GH
    Semin Liver Dis; 1998; 18(1):67-75. PubMed ID: 9516680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C, porphyria cutanea tarda and liver iron: an update.
    Ryan Caballes F; Sendi H; Bonkovsky HL
    Liver Int; 2012 Jul; 32(6):880-93. PubMed ID: 22510500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda.
    Khoo BP; Tay YK
    Singapore Med J; 2000 Jun; 41(6):292-4. PubMed ID: 11109347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
    Franklin MR; Phillips JD; Kushner JP
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
    Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme.
    Thunell S; Harper P
    Scand J Clin Lab Invest; 2000 Nov; 60(7):561-79. PubMed ID: 11202050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.